About Celleration
Celleration is a Healthcare company based in Eden Prairie (United States) founded in 1999, and was acquired by Alliqua in February 2015. Ultrasound technology for wound healing is developed and marketed. Celleration has raised $70.57 million across 7 funding rounds from investors including Indiana University Health, Alliqua and Affinity Capital Management. The company has 43 employees. The company was acqui-hired. Its focus areas include Life Sciences, Wound Care, Medical Devices and Therapeutic Devices. Its legal entity is CELLERATION INC. Its competitors include Biofisica, BioElectronics Corporation and Vomaris Innovations; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 1999 and headquartered in Eden Prairie, United States, Celleration operates as a medical device company focused on ultrasound technology for wound treatment. Proprietary low-frequency ultrasound is delivered via a saline mist through the MIST Therapy System, which received FDA 510(k) clearance in 2005 for promoting wound healing. Treatments have been administered over one million times in the United States and United Kingdom, serving more than 65,000 patients.
- Headquarters Eden Prairie, United States
- Employees 43
- Stage Acquired
- SectorsHealthcare
- Website celleration.com
- Acquired by Alliqua (Feb 2015)
- Legal Name Celleration Inc.
- Total Equity Funding$70.57M (USD)
in 7 rounds
- Latest Funding Round$6.42M (USD), Series E
Jan 2013
- InvestorsIndiana University Health
& 12 more
- Employee Count43
- Acquired byAlliqua
(Feb 2015)
Funding Insights of Celleration
Celleration has successfully raised a total of $70.57M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $6.42 million completed in January 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $70.57M
- Total Rounds 7
- Last Round Series E — $6.42M
- First Round $2.03M
(Oct 2004)
- Investors Count 12
All 7 funding rounds of Celleration with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2013 | $6.42M | Series E | – | – | – |
| Jan 2011 | $8M | Series E | – | – | |
| Aug 2008 | $30M | Series D | – | – | |
| Nov 2005 | $20.6M | Series C | – | – | |
| Jun 2005 | $1M | Series A | – | – | – |
| Dec 2004 | $2.52M | Series A | – | – | – |
| Oct 2004 | $2.03M | Series A | – | – | – |
13 investors in total: 13 institutional.
Investors in Celleration
Celleration has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Indiana University Health, Alliqua and Affinity Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| affinitycapital.net | ||||
Multiple sectors focused seed & early stage VC firm investing in the US, Europe & Asia | ventureinvestors.com | Madison, United States | ||
A venture fund focused on medical sector investments is managed. | tmvp.com | |||
Global private equity and venture capital investments in B2B Tech & Services companies. | bairdcapital.com | |||
Early, mid, and late-stage investments are made in science sectors. | newscienceventures.com | New York, United States | ||
Heron Capital is engaged in private equity investment management. | heroncap.com | Indianapolis, United States | ||
Private equity investments in the US are managed by AAVIN. | aavin.com | Cedar Rapids, United States | ||
CID Capital is engaged in lower-middle-market buyout investments. | 1981 | cidcap.com | Carmel, United States | |
A Chicago-based private equity firm currently in wind-down. | 1999 | prismfund.com | Glenview, United States | |
Seneca Partners is recognized as a leading independent sponsor in North America. | senecapartners.com | Detroit, United States |
Investor details for Celleration
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Celleration
4 dated milestones of Celleration across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Celleration is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Series E, of $6.4M.
- Exit Acquired by Alliqua.
Competitors of Celleration
Celleration has 3 listed competitors in our database, 2 of them funded. They include Biofisica, BioElectronics Corporation and Vomaris Innovations.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biofisica.com | 2000 | Atlanta, United States | $7.3M | Develops electrical stimulation devices to promote wound healing. | ||
| bielcorp.com | 2000 | Frederick, United States | Medical devices are developed to reduce pain and inflammation. | |||
| vomaris.com | 2004 | Phoenix, United States | $16.2M | Bio-mimicking microcurrent technology is applied to wound healing. |
Detailed competitors of Celleration
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Wound Care
3 companies that operate in the same segment as Celleration (Wound Care) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | 35 | ||
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | USD 418.63 M | 837 | ||
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Celleration
Celleration was founded in 1999 and raised its 1st funding round 5 years after it was founded.
Celleration is headquartered in Eden Prairie, United States. It is registered at Eden Prairie, Minnesota, United States.
Celleration is a funded company, having raised a total of $70.57M across 7 funding rounds to date. The company's 1st funding round was a Series A of $2.03M, raised on Oct 2004.
Celleration has 43 employees.
Founded in 1999 and headquartered in Eden Prairie, United States, Celleration operates as a medical device company focused on ultrasound technology for wound treatment. Proprietary low-frequency ultrasound is delivered via a saline mist through the MIST Therapy System, which received FDA 510(k) clearance in 2005 for promoting wound healing. Treatments have been administered over one million times in the United States and United Kingdom, serving more than 65,000 patients.
Celleration's top competitors include BioElectronics Corporation, Vomaris Innovations and Biofisica.
Celleration has 13 investors. Key investors include Indiana University Health, Alliqua, Affinity Capital Management, Venture Investors, and Triathlon Medical Ventures.
Celleration operates through Celleration Inc..
Yes. Celleration was acquired by Alliqua in February 2015.